FDA Inspection 1301824 — Tarmac Products, Inc.

Tarmac Products, Inc. — FEI 1025483

The FDA completed an inspection of Tarmac Products, Inc. on February 6, 2026 in Miami Gardens, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 6, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami Gardens, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
144821 CFR 211.111Establishment of time limitations
354721 CFR 211.46(b)Equipment for Environmental Control
356721 CFR 211.84(d)(2)Component identification test